Dealmaking in Europe’s life sciences sector has been relatively muted in recent years, but the first half of 2025 has shown signs of strength as companies respond to the stark realities of an aging population -
Earlier this...more
7/23/2025
/ Acquisitions ,
Artificial Intelligence ,
EU ,
European Commission ,
Healthcare ,
Life Sciences ,
Mergers ,
Pharmaceutical Industry ,
Popular ,
Private Equity ,
Technology
In response to the COVID-19 emergency, the screening powers of the Italian government were significantly expanded -
The Italian government, led by the President of the Council of Ministries, together with any other...more
12/31/2021
/ Acquisitions ,
Coronavirus/COVID-19 ,
Corporate Governance ,
Critical Infrastructure Sectors ,
EU ,
European Commission ,
Filing Requirements ,
Foreign Direct Investment ,
Investors ,
Italy ,
Power Infrastructure ,
Sanctions